Astrana Health (ASTH) | Stock Overview & Key Data

What is ASTH's 52-week high and low?

In the last 52 weeks, Astrana Health reached a high of $63.20 (on October 16, 2024) and a low of $23.12 (on February 28, 2025).

What is the market cap and P/E ratio for ASTH?

Curious about Astrana Health's size and valuation? Its market capitalization stands at 1.11B. When it comes to valuation, the P/E ratio (trailing twelve months) is 32.88, and the forward P/E (looking ahead) is 15.69.

Does ASTH pay dividends? If so, what's the yield?

As for dividends, Astrana Health isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Astrana Health's main competitors or similar companies to consider before investing?

When looking at Astrana Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
HCA Healthcare HCA	90.82B	Healthcare	Medical Care Facilities	17.57%	118.18%
Tenet Healthcare THC	15.71B	Healthcare	Medical Care Facilities	30.12%	211.03%
Select Medical SEM	1.85B	Healthcare	Medical Care Facilities	-22.20%	9.39%
National Healthcare NHC	1.65B	Healthcare	Medical Care Facilities	-5.09%	56.30%
Pacs PACS	2.05B	Healthcare	Medical Care Facilities	-55.55%	-45.25%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Astrana Health Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Astrana Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.10%, the Debt to Equity ratio from the most recent quarter is 87.19, and its Gross Profit Margin stands at 11.50%.

What is the recent revenue and earnings growth for ASTH?

Looking at Astrana Health's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 53.40%, and quarterly earnings saw a YoY growth of -54.90%.

How much of ASTH stock is held by insiders and institutions?

Wondering who owns Astrana Health stock? Company insiders (like executives and directors) hold about 22.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 53.99%.

For more common questions about our data, please visit our About Data page.